<DOC>
	<DOCNO>NCT02026921</DOCNO>
	<brief_summary>A phase II single arm study carboplatin docetaxel treatment first sensitive relapse epithelial ovarian , peritoneal tubal cancer . Hypothesis : Treatment combination second line safe low frequency neurologic side effect .</brief_summary>
	<brief_title>A Phase II Study Docetaxel Carboplatin Late Relapse Ovarian Cancer</brief_title>
	<detailed_description>Evaluation toxicity response treatment carboplatin docetaxel patient epithelial cancer ovary , fallopian tube peritoneum first relapse occur least 6 month end first line treatment- Evaluation toxicity accord Clinical Toxicity Criteria version 2 .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Epithelial carcinoma ovarian , peritoneal fallopian tube origin . Female age 18 year WHO performance status 02 Life expectancy &gt; 3 month Previous treatment one platinum taxane contain regimen . Platinum taxane sensitive relapse At least one evaluable/measurable lesion . Adequate hematologic , renal liver function Consent form sign dated inclusion Prior treatment one line chemotherapy Concurrent severe and/or uncontrolled comorbid medical condition . History previous concurrent malignancy within previous 5 year • History prior serious allergic reaction anaphylactic shock Pregnant lactate woman ( potentially fertile woman use adequate contraception ) Peripheral neuropathy &gt; Grade 2 History allergy drug contain excipient TWEEN 80® . Concomitant administration experimental drug investigation concurrent treatment anticancer therapy Clinical evidence brain metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Phase II study ,</keyword>
	<keyword>Recurrent platinum-sensitive ovarian cancer</keyword>
	<keyword>docetaxel</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Toxicity</keyword>
</DOC>